Maintenance metronomic chemotherapy for metastatic/recurrent nasopharyngeal carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Maintenance metronomic chemotherapy for metastatic/recurrent nasopharyngeal carcinoma

Published:2022-04 Issue:6 Volume:44 Page:1453-1461
ISSN:1043-3074
Container-title:Head & Neck
language:en
Short-container-title:Head & Neck

Author:

Twu Chih‐Wen¹²,Lin Po‐Ju³,Tsou Hsiao‐Hui⁴⁵,Liu Yi‐Chun⁶,Jiang Rong‐San⁷,Liang Kai‐Li⁷^ORCID,Lin Tian‐Yun⁷,Wang Wen‐Yi⁸,Lin Jin‐Ching³⁶⁹^ORCID

Affiliation:

1. Department of Otorhinolaryngology – Head and Neck Surgery Changhua Christian Hospital Changhua Taiwan

2. College of Medicine National Chung Hsing University Taichung Taiwan

3. Department of Radiation Oncology Changhua Christian Hospital Changhua Taiwan

4. Institute of Population Health Sciences National Health Research Institutes Miaoli Taiwan

5. Graduate Institute of Biostatistics College of Public Health, China Medical University Taichung Taiwan

6. Department of Radiation Oncology Taichung Veterans General Hospital Taichung Taiwan

7. Department of Otorhinolaryngology – Head and Neck Surgery Taichung Veterans General Hospital Taichung Taiwan

8. Department of Nursing Hung Kuang University Taichung Taiwan

9. Institute of Clinical Medicine, School of Medicine National Yang‐Ming Chiao‐Tung University Taipei Taiwan

Funder

Ministry of Science and Technology

Publisher

Wiley

Subject

Otorhinolaryngology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hed.27044

Reference37 articles.

1. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.

2. Randomized Trial of Radiotherapy Versus Concurrent Chemoradiotherapy Followed by Adjuvant Chemotherapy in Patients With American Joint Committee on Cancer/International Union Against Cancer Stage III and IV Nasopharyngeal Cancer of the Endemic Variety

3. Preliminary Results of a Prospective Randomized Trial Comparing Concurrent Chemoradiotherapy Plus Adjuvant Chemotherapy With Radiotherapy Alone in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma in Endemic Regions of China

4. Factors contributing to the efficacy of concurrent–adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: Combined analyses of NPC-9901 and NPC-9902 Trials

5. Phase III Study of Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Advanced Nasopharyngeal Carcinoma: Positive Effect on Overall and Progression-Free Survival

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maintenance treatment with oral anticancer agents after first-line chemotherapy in patients with recurrent or metastatic nasopharyngeal carcinoma: a systematic review and meta-analysis;European Archives of Oto-Rhino-Laryngology;2024-08-28

2. Failure patterns and individualized treatment plans of reirradiation for inoperable locally recurrent nasopharyngeal carcinoma;Scientific Reports;2024-08-02

3. Long-term efficacy analysis of radiotherapy and local management of metastases in patients with newly diagnosed oligometastatic nasopharyngeal carcinoma: A prospective, single-arm, single-center clinical study;Radiotherapy and Oncology;2024-07

4. Metronomic chemotherapy in cancer treatment: new wine in an old bottle;Theranostics;2024

5. Computational simulations of tumor growth and treatment response: Benefits of high-frequency, low-dose drug regimens and concurrent vascular normalization;PLOS Computational Biology;2023-06-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3